Advanced Enzyme Technologies (ADVENZYMES) — Board Meeting

Advanced Enzyme Technologies announced that Independent Director Ms. Rajshree Patel (DIN 08761022) will cease to be a director effective June 11, 2026, upon completion of her second consecutive term, as mandated by SEBI Listing Regulations.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ADVENZYMES ✨ Ask AI About This

About Advanced Enzyme Technologies Limited (ADVENZYMES)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,071.34 Cr P/E: 24.1 ROE: 10.3% ROCE: 13.8%

View full ADVENZYMES stock details →

📡 Get AI alerts when ADVENZYMES files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ADVENZYMES — Free

💡 Ask AI about this filing

"How does this board meeting affect Advanced Enzyme Technologies Limited's outlook?" "What did Advanced Enzyme Technologies Limited announce on 11 June 2026?" "Is this positive or negative for ADVENZYMES?"

Ask AI Free →

📊 More ADVENZYMES filings

See all ADVENZYMES filings →

🔥 Also filed on 11 June 2026

RGL Renaissance Global Limited Insider Trading RMCL Radha Madhav Corporation Limited Insider Trading RANEHOLDIN Rane Holdings Limited Announcement RBLBANK RBL Bank Limited Insider Trading RELTD Ravindra Energy Limited Insider Trading SEJALLTD Sejal Glass Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ADVENZYMES files new disclosures

Track ADVENZYMES filings, board meetings, and corporate actions. Free email alerts at 5 PM.